# Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy

> **NCT04278469** · NA · RECRUITING · sponsor: **Gencurix, Inc.** · enrollment: 194 (estimated)

## Conditions studied

- Early Hormone Receptor-positive Breast Cancer

## Interventions

- **DRUG:** Chemotherapy Drugs, Cancer

## Key facts

- **NCT ID:** NCT04278469
- **Lead sponsor:** Gencurix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-11
- **Primary completion:** 2029-01
- **Final completion:** 2029-01
- **Target enrollment:** 194 (ESTIMATED)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04278469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04278469, "Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04278469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*